Modeling metabolic effects of the HIV protease inhibitor ritonavir in vitro

Am J Pathol. 2007 Nov;171(5):1724; author reply 1725. doi: 10.2353/ajpath.2007.070667. Epub 2007 Sep 14.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cholesterol / metabolism*
  • Foam Cells / drug effects*
  • Foam Cells / metabolism
  • HIV Protease Inhibitors / administration & dosage
  • HIV Protease Inhibitors / adverse effects
  • HIV Protease Inhibitors / pharmacology*
  • Humans
  • Ritonavir / administration & dosage
  • Ritonavir / adverse effects
  • Ritonavir / pharmacology*

Substances

  • HIV Protease Inhibitors
  • Cholesterol
  • Ritonavir